To assess interindividual variation in expression of these IFN gene signatures, we calculated z-score–based IFN-α and -γ scores for each sample, showing that COVID-19 patients display significantly increased yet variable IFN scores relative to controls (Fig. 1C and SI Appendix, Fig. S1A). This evidence concerns the gene IFNA2 and COVID-19.